Early and nonreversible decrease of CD161++/MAIT cells in HIV infection

Blood

Volumn 121, Issue 6, 2013, Pages 951-961

  Cosgrove, Cormac ^a   Ussher, James E ^a   Rauch, Andri ^b   Gärtner, Kathleen ^c   Kurioka, Ayako ^a   Hühn, Michael H ^d   Adelmann, Krista ^a   Kang, Yu Hoi ^a   Fergusson, Joannah R ^a   Simmonds, Peter ^c   Goulder, Philip ^a   Hansen, Ted H ^e   Fox, Julie ^f   Günthard, Huldrych F ^g   Khanna, Nina ^h   Powrie, Fiona ^d   Steel, Alan ⁱ   Gazzard, Brian ⁱ   Phillips, Rodney E ^a   Frater, John ^a   Uhlig, Holm ^d   Klenerman, Paul ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c Ashworth Laboratories   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BLOOD; CD8+ T LYMPHOCYTE; CELL DEATH; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTESTINE MUCOSA; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TISSUES;

EID: 84873592714     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-436436     Document Type: Article

References (54)

1. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol. 2003;77(21):11708-11717. (Pubitemid 37271669)
2. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749-759. (Pubitemid 39299461)
3. Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200(6):761-770. (Pubitemid 39299462)
4. Lim SG, Condez A, Lee CA, et al. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol. 1993;92(3):448-454. (Pubitemid 23183754)
5. Greenspan D, Greenspan J. HIV-related oral disease. Lancet. 1996;348(9029):729-733. (Pubitemid 26302311)
6. Djoba Siawaya JF, Ruhwald M, Eugen-Olsen J, Walzl G. Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int J Infect Dis. 2007;11(4):289-299. (Pubitemid 46994763)
7. Geldmacher C, Schuetz A. Early depletion of mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J Infect Dis. 2008;198(11):1590-1598.
8. Gohil SK, Heo M, Schoenbaum E, Celentano D, Pirofski L-A. CD8- T cells and risk for bacterial pneumonia and all-cause mortality among HIVinfected women. J Acquir Immune Defic Syndr. 2012;60:191-198.
9. Gold MC, Cerri S, Smyk-Pearson S, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 2010; 8(6): e1000407.
10. Le Bourhis L, Martin E, Péguillet I, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol. 2010;11(8):701-U66.
11. Billerbeck E, Kang Y-H, Walker L, et al. Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissuehoming properties. PNAS. 2010;107(7):3006-3011.
12. Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic-resistant, tissuetargeted, CD161(hi) IL-17-secreting T cells. Blood. 2011;117(4):1250-1259.
13. Walker LJ, Kang Y-H, Smith MO, et al. Human MAIT and CD8αα cells develop from a pool of type-17 pre-committed CD8+ T cells. Blood. 2012;119(2):422-433.
14. Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature. 2003;422(6928): 164-169. (Pubitemid 36362748)
15. Georgel P, Radosavljevic M, Macquin C, Bahram S. The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Mol Immunol. 2011;48(5):769-775.
16. Chung DR, Kasper DL, Panzo RJ, et al. CD4+ T cells mediate abscess formation in intraabdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003;170(4):1958-1963. (Pubitemid 36197415)
17. Brand S, Beigel F, Olszak T, et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am J Physiol Gastrointest Liver Physiol. 2006;290(4):G827-38.
18. Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-544. (Pubitemid 351206544)
19. Maggi L, Santarlasci V, Capone M, et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40(8):2174-2181.
20. Puel A, Cypowyj S, Bustamante J, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 2011;332(6025):65-68.
21. Macal M, Sankaran S, Chun TW, et al. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIVspecific T-cell responses. Mucosal Immunol. 2008;1(6):475-488.
22. Raffatellu M, Santos RL, Verhoeven DE, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med. 2008;14(4): 421-428. (Pubitemid 351499394)
23. Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009;7(3):e1000054.
24. Livingstone WJ, Moore M, Innes D, Bell JE, Simmonds P. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet. 1996;348(9028):649-654. (Pubitemid 26293810)
25. Estes JD, Harris LD, Klatt NR, et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog. 2010; 6(8): e1001052.
26. Connolly GM, Shanson D, Hawkins DA, Webster JN, Gazzard BG. Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut. 1989;30(2):195-200. (Pubitemid 19058872)
27. Geremia A, Arancibia-Carcamo CV, Fleming MPP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med. 2011;208(6):1127-1133.
28. Jones TR, Carpenter AE, Lamprecht MR, et al. Scoring diverse cellular morphologies in imagebased screens with iterative feedback and machine learning. PNAS. 2009;106(6):1826-1831.
29. Fergusson JR, Fleming VM, Klenerman P. Frontiers: CD161-expressing human T cells. Front Immunol. 2011;2(36):1-7.
30. Mehandru S, Poles MA, Tenner-Racz K, et al. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 2006;3(12):e484.
31. Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity. 2009;31(5):834-844.
32. Schneider T, Ullrich R, Bergs C, et al. Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group. Clin Exp Immunol. 1994; 95(3):430-435. (Pubitemid 24210184)
33. De Maria A, Pantaleo G, Schnittman SM, et al. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J Immunol. 1991;146(7): 2220-2226.
34. Brenchley JM, Hill BJ, Ambrozak DR, et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol. 2004;78(3):1160-1168. (Pubitemid 38095826)
35. Kitchen SG, Korin YD, Roth MD, Landay A, Zack JA. Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J Virol. 1998; 72(11):9054-9060. (Pubitemid 28471849)
36. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12(12):1365-1371. (Pubitemid 44924494)
37. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009;199(8):1177-1185.
38. Northfield JW, Kasprowicz V, Lucas M, et al. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology. 2008;47(2):396-406. (Pubitemid 351280707)
39. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998; 279(5359):2103-2106. (Pubitemid 28196353)
40. Ogg GS, Jin X, Bonhoeffer S, et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J Virol. 1999;73(1):797-800. (Pubitemid 28565430)
41. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190(3):624-631. (Pubitemid 38982105)
42. Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during mycobacterium tuberculosis challenge. Nat Immunol. 2007;8(4):369-377. (Pubitemid 46745412)
43. Nigam P, Kwa S, Velu V, Amara RR. Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection. J Immunol. 2011;186(2):745-753.
44. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002;51(6):818-826. (Pubitemid 35408603)
45. Baba M, Imai T, Nishimura M, et al. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem. 1997;272(23):14893-14898. (Pubitemid 27251760)
46. Mehandru S, Poles M, Tenner-Racz K. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81(2):599-612. (Pubitemid 46067887)
47. Choi YK, Whelton KM, Mlechick B, Murphey-Corb MA, Reinhart TA. Productive infection of dendritic cells by simian immunodeficiency virus in macaque intestinal tissues. J Pathol. 2003;201(4): 616-628. (Pubitemid 38256412)
48. Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE. Intestinal permeability and function in patients infected with human immunodeficiency virus: a comparison with coeliac disease. Scand J Gastroenterol. 1993;28:573-580. (Pubitemid 23192684)
49. Keating J, Bjarnason I, Somasundaram S, et al. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut. 1995;37(5):623-629.
50. Epple H-J, Schneider T, Troeger H, et al. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIVinfected patients. Gut. 2009;58(2):220-227.
51. Lécureuil C, Combadiè re B, Mazoyer E, et al. Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients. Blood. 2007; 109(9):3649-3657. (Pubitemid 46641711)
52. Shankarappa R, Margolick JB, Gange SJ, et al. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol. 1999;73(12):10489-10502.
53. Rieder P, Joos B, Scherrer AU, et al. Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection. Clin Infect Dis. 2011; 53(12):1271-1279.
54. Sonnenberg P, Glynn JR, Fielding K, et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis. 2005;191(2):150-158. (Pubitemid 40096371)